Sumy Pharmaceuticals Pvt. Ltd.

OHM-20

Omeprazole 20 mg tablet

Mode of action
OHM is a substitutes benzimidazole gastric anti secretory agent and is also known as PPI. It blocks the final step in gastric acid selection by specific inhibition of H+/K+ATPase enzyme, which is present on the surface of the gastric parietal cell.
Indication
- Peptic ulcer
- pylori infection
- Gastro-oesophageal reflux diseases
- Zollinger Ellison syndrome
- Oesophagitis
- Acid related dyspepsia
- NSAID associated ulceration
Dose
Usual Adult Dose for Gastric Ulcer

40 mg orally once a day
-Duration of therapy: 4 to 8 weeks

Use: Short-term treatment of active benign gastric ulcer

Usual Adult Dose for Erosive Esophagitis

Treatment: 20 mg orally once a day
-Duration of therapy: 4 to 8 weeks

Maintenance: 20 mg orally once a day

Usual Adult Dose for Duodenal Ulcer

20 mg orally once a day
-Duration of therapy: 4 weeks

Use: Short-term treatment of active duodenal ulcer

Usual Adult Dose for Helicobacter pylori Infection

Dual therapy: 40 mg orally once a day, taken concomitantly with clarithromycin
-Duration of therapy: 14 days

Usual Adult Dose for Zollinger-Ellison Syndrome

Initial dose: 60 mg orally once a day
Maximum dose: 360 mg/day (as 120 mg orally 3 times a day)

Usual Adult Dose for Gastroesophageal Reflux Disease

20 mg orally once a day
-Duration of therapy: Up to 4 weeks

Use: Treatment of heartburn and other symptoms associated with GERD

Usual Adult Dose for Dyspepsia

Over-the-Counter (OTC) formulations: 20 mg orally once a day in the morning
-Duration of therapy: 14 days